首页 >
法规速递
-
Page: ICH Q3E Extractables and leachables - scientific guideline-2026/1/28
2026-01-29查看详情 > -
关于公开征求《治疗用重组蛋白药物上市许可申请质量综述资料撰写指导原则（征求意见稿）》等三个指导原则意见的通知-2026/3/9
2026-03-10查看详情 > -
Page: Data protection and privacy at EMA-2026/4/7
2026-04-08查看详情 > -
Page: Data Analysis and Real World Interrogation Network (DARWIN EU)-2026/5/20
2026-05-21查看详情 > -
关于公开征求《罕见疾病药物开发中疾病自然史研究指导原则》意见的通知-2022/12/21
2022-12-22查看详情 > -
国家药监局综合司公开征求《药品说明书适老化改革试点工作方案》等文件意见-2023/6/29
2023-06-30查看详情 > -
Final Guidance: Reformulating Drug Products That Contain Carbomers Manufactured With Benzene-2023/12/27
2024-01-03查看详情 > -
Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)-2025/1/31
2025-02-05查看详情 > -
Document: Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations-2025/2/27
2025-03-03查看详情 > -
Document: Highlight report - 13th Industry stakeholder platform on research and development support-2025/4/4
2025-04-07查看详情 >
